Concepedia

Juji Dai

JD

Statistics

Publications

11

Citations

839

H-Index

10

Active since

2015

Affiliations

Wenzhou Medical University(Current)

First Affiliated Hospital of Wenzhou Medical University

Juji Dai is an author at Wenzhou Medical University specializing in oncology, medicine, and cancer cell signaling.

ORCID

Publications per year

2015–2022

11

Publications

11

Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer

Jiawen Yang, Jiajie Mo, Juji Dai et al. · Cell Death and Disease · 2021 · 298 citations · Full text

, , +17

AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway

Tianke Chen, Xiaowei Dai, Juji Dai et al. · Cell Death and Disease · 2020 · 185 citations · Full text

, , +17

Luteolin decreases invasiveness, deactivates STAT3 signaling, and reverses interleukin-6 induced epithelial–mesenchymal transition and matrix metalloproteinase secretion of pancreatic cancer cells

Xince Huang, Shengjie Dai, Juji Dai et al. · OncoTargets and Therapy · 2015 · 107 citations · Full text

, , +15

RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway

Xiaoming Dong, Wanqin Liao, Li Zhang et al. · Cancer Letters · 2017 · 71 citations

, , +14

Induction of autophagy by salidroside through the AMPK-mTOR pathway protects vascular endothelial cells from oxidative stress-induced apoptosis

Xiangtao Zheng, Ziheng Wu, Ye Wei et al. · Molecular and Cellular Biochemistry · 2016 · 65 citations

, , +16

1–5 of 11